Drug Shortage Report for ENSPRYNG
| Report ID | 227132 |
| Drug Identification Number | 02499681 |
| Brand name | ENSPRYNG |
| Common or Proper name | Satralizumab |
| Company Name | HOFFMANN-LA ROCHE LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | SATRALIZUMAB |
| Strength(s) | 120MG |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS |
| Packaging size | 120MG Pre-filled Syringe |
| ATC code | L04AC |
| ATC description | |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | 2024-05-15 |
| Actual start date | |
| Estimated end date | 2024-06-28 |
| Actual end date | 2024-05-14 |
| Shortage status | Avoided shortage |
| Updated date | 2024-05-14 |
| Company comments | Resolved before anticipated start date. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 7070 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 5M8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2024-05-14 | French | Compare |
| v3 | 2024-05-14 | English | Compare |
| v2 | 2024-05-06 | French | Compare |
| v1 | 2024-05-06 | English | Compare |
Showing 1 to 4 of 4